Skip to main content

Publication, Part of

National Pregnancy in Diabetes Audit Dashboard 2024 (01 January 2022 to 31 December 2024)

Audit

Publication Date:
9 Oct 2025
Geographic Coverage:
England, Wales
Geographical Granularity:
Country, Regions, NHS Trusts, Hospital Trusts, Hospital and Community Health Services
Page contents

Summary

The National Pregnancy in Diabetes Audit (NPID) is a workstream of the National Diabetes Audit (NDA). It aims to support clinical teams to deliver better care and outcomes for women with diabetes who become pregnant and has been running since 2014.

The dashboard presents service level data and is intended to support local, regional and national quality improvement. The latest version of the dashboard reports on data collected for pregnancies that ended between 1 January 2022 and 31 December 2024 and includes data on continuous glucose monitoring (CGM).

Data are submitted by antenatal services in England and Wales.

Highlights

There are 3 data files provided in this publication:

  • A detailed analysis file which includes an overview of the NPID dataset, presenting key metrics at a national level.
  • 2 open data files which provide all the breakdowns presented in the dashboard. The first contains the data for demographics, preparation and outcomes and the second contains data for continuous glucose monitoring.

Change to NDA reporting

NHS England are currently reviewing the routine production of NDA State of the Nation reports. Please note that data will still be released via dashboards and standalone data files whilst this review is being conducted.

To help inform this review we would be grateful if users can provide feedback on their use of the State of the Nation reports using the feedback survey available in the ‘Related links' section of this page.

Key Facts

The increasing prevalence of pregnancies complicated by early-onset type 2 diabetes continues.

During 2024, there were 3,520 (60.2%) recorded pregnancies in women with type 2 diabetes (46.9% in 2014), and 2,240 (38.3%) pregnancies in women with type 1 diabetes (51.5% in 2014).

Rates of serious adverse pregnancy outcomes are higher in pregnancies complicated by type 2 diabetes.

In 2024, rates of serious adverse pregnancy outcomes (major congenital anomaly & perinatal deaths) were higher in pregnancies complicated by type 2 diabetes (5.3%) compared with type 1 diabetes (4.7%).

Pregnancy preparation has improved in type 1 diabetes without improvement in type 2 diabetes.

Pregnancy preparation has improved in type 1 diabetes (12.7% in 2014-18 compared with 18.3% in 2024) without improvement in type 2 diabetes (12.0% in 2014-18 compared with 10.2% in 2024).

Maternal glucose levels are improving during pregnancy in women with type 1 diabetes without improvement in type 2 diabetes.

30.9% of women with type 1 diabetes achieving late pregnancy HbA1c target of <43mmol/mol in 2022-2024 compared to 23.2% (2014-2018).

51.7% of women with type 2 diabetes achieving late pregnancy HbA1c target of <43mmol/mol in 2022-2024 compared to 54.7% (2014-2018).

Most women with type 1 diabetes enter pregnancy already using continuous glucose monitoring (CGM).

In 2024, most women with type 1 diabetes (90.1%) enter pregnancy already using CGM, with almost all (97.5%) now using CGM during pregnancy.

Interactive data visualisation

National Diabetes Audit dashboards

In order to access this visualisation and its functionality, we recommend the following internet browsers:

Microsoft Edge

Chrome desktop latest version

Safari Mac latest version

Firefox desktop latest version

Last edited: 9 October 2025 9:32 am